TALDO1 | OmnibusX

I. Expression across cell types

Name	Number of supported studies	Average coverage
macrophage	33 studies	45% ± 17%	Explore
B cell	29 studies	31% ± 11%	Explore
fibroblast	29 studies	28% ± 14%	Explore
conventional dendritic cell	28 studies	53% ± 21%	Explore
classical monocyte	27 studies	68% ± 19%	Explore
natural killer cell	25 studies	27% ± 12%	Explore
non-classical monocyte	24 studies	61% ± 17%	Explore
CD4-positive, alpha-beta T cell	23 studies	32% ± 20%	Explore
CD8-positive, alpha-beta T cell	22 studies	34% ± 19%	Explore
regulatory T cell	22 studies	33% ± 15%	Explore
smooth muscle cell	21 studies	24% ± 7%	Explore
epithelial cell	21 studies	43% ± 20%	Explore
endothelial cell	21 studies	29% ± 11%	Explore
pericyte	21 studies	25% ± 9%	Explore
T cell	20 studies	31% ± 12%	Explore
plasmacytoid dendritic cell	20 studies	47% ± 15%	Explore
basal cell	20 studies	37% ± 17%	Explore
dendritic cell	19 studies	52% ± 22%	Explore
monocyte	19 studies	56% ± 16%	Explore
mast cell	17 studies	33% ± 9%	Explore
memory B cell	17 studies	28% ± 12%	Explore
ciliated cell	16 studies	46% ± 14%	Explore
plasma cell	14 studies	39% ± 15%	Explore
myeloid cell	14 studies	55% ± 23%	Explore
gamma-delta T cell	14 studies	27% ± 16%	Explore
neutrophil	13 studies	49% ± 16%	Explore
myofibroblast cell	13 studies	29% ± 9%	Explore
secretory cell	12 studies	39% ± 16%	Explore
connective tissue cell	12 studies	32% ± 11%	Explore
endothelial cell of lymphatic vessel	11 studies	26% ± 9%	Explore
erythrocyte	11 studies	51% ± 25%	Explore
CD16-positive, CD56-dim natural killer cell, human	11 studies	26% ± 6%	Explore
naive B cell	11 studies	24% ± 7%	Explore
naive thymus-derived CD4-positive, alpha-beta T cell	11 studies	24% ± 6%	Explore
naive thymus-derived CD8-positive, alpha-beta T cell	11 studies	27% ± 10%	Explore
mature NK T cell	11 studies	22% ± 6%	Explore
plasmablast	10 studies	49% ± 22%	Explore
platelet	10 studies	52% ± 15%	Explore
CD16-negative, CD56-bright natural killer cell, human	10 studies	27% ± 7%	Explore
capillary endothelial cell	10 studies	23% ± 10%	Explore
abnormal cell	10 studies	30% ± 10%	Explore
oligodendrocyte	10 studies	31% ± 12%	Explore
CD4-positive, alpha-beta memory T cell	9 studies	33% ± 15%	Explore
CD8-positive, alpha-beta memory T cell	9 studies	31% ± 17%	Explore
progenitor cell	9 studies	40% ± 22%	Explore
hematopoietic stem cell	9 studies	73% ± 23%	Explore
mucosal invariant T cell	9 studies	23% ± 5%	Explore
type I pneumocyte	8 studies	36% ± 10%	Explore
effector memory CD8-positive, alpha-beta T cell	8 studies	27% ± 8%	Explore
goblet cell	8 studies	30% ± 14%	Explore
type II pneumocyte	7 studies	33% ± 15%	Explore
club cell	7 studies	43% ± 8%	Explore
leukocyte	7 studies	34% ± 15%	Explore
neuron	7 studies	39% ± 17%	Explore
endothelial cell of artery	7 studies	20% ± 3%	Explore
vein endothelial cell	7 studies	24% ± 8%	Explore
alveolar macrophage	6 studies	52% ± 13%	Explore
hematopoietic precursor cell	6 studies	69% ± 26%	Explore
respiratory goblet cell	6 studies	44% ± 19%	Explore
mononuclear phagocyte	6 studies	44% ± 18%	Explore
epithelial cell of proximal tubule	6 studies	31% ± 6%	Explore
megakaryocyte	6 studies	70% ± 25%	Explore
innate lymphoid cell	6 studies	24% ± 9%	Explore
ionocyte	5 studies	30% ± 10%	Explore
kidney loop of Henle epithelial cell	5 studies	32% ± 8%	Explore
enterocyte	5 studies	21% ± 4%	Explore
enteroendocrine cell	5 studies	35% ± 15%	Explore
erythroblast	5 studies	63% ± 28%	Explore
mesothelial cell	5 studies	38% ± 18%	Explore
transit amplifying cell	5 studies	31% ± 11%	Explore
brush cell	5 studies	34% ± 15%	Explore
immature B cell	5 studies	38% ± 23%	Explore
precursor B cell	5 studies	43% ± 16%	Explore
astrocyte	5 studies	26% ± 8%	Explore
T follicular helper cell	5 studies	23% ± 3%	Explore
effector CD8-positive, alpha-beta T cell	5 studies	50% ± 22%	Explore
endothelial cell of vascular tree	5 studies	25% ± 3%	Explore
oligodendrocyte precursor cell	5 studies	33% ± 9%	Explore
deuterosomal cell	4 studies	27% ± 8%	Explore
squamous epithelial cell	4 studies	53% ± 21%	Explore
pancreatic A cell	4 studies	41% ± 17%	Explore
type B pancreatic cell	4 studies	38% ± 14%	Explore
exhausted T cell	4 studies	45% ± 14%	Explore
intestinal crypt stem cell	4 studies	25% ± 10%	Explore
pro-B cell	4 studies	48% ± 4%	Explore
microglial cell	4 studies	31% ± 11%	Explore
adventitial cell	4 studies	25% ± 3%	Explore
adipocyte	4 studies	31% ± 21%	Explore
effector CD4-positive, alpha-beta T cell	4 studies	54% ± 9%	Explore
intermediate monocyte	4 studies	77% ± 9%	Explore
luminal hormone-sensing cell of mammary gland	4 studies	30% ± 9%	Explore
inflammatory macrophage	4 studies	31% ± 7%	Explore
granulocyte	4 studies	49% ± 15%	Explore
glutamatergic neuron	4 studies	38% ± 7%	Explore
effector memory CD4-positive, alpha-beta T cell	4 studies	44% ± 17%	Explore
megakaryocyte-erythroid progenitor cell	4 studies	73% ± 31%	Explore
effector memory CD8-positive, alpha-beta T cell, terminally differentiated	4 studies	25% ± 9%	Explore
duct epithelial cell	3 studies	40% ± 12%	Explore
precursor cell	3 studies	70% ± 12%	Explore
monocyte-derived dendritic cell	3 studies	60% ± 13%	Explore
glomerular endothelial cell	3 studies	20% ± 4%	Explore
kidney distal convoluted tubule epithelial cell	3 studies	40% ± 13%	Explore
renal alpha-intercalated cell	3 studies	33% ± 4%	Explore
neural crest cell	3 studies	36% ± 8%	Explore
extravillous trophoblast	3 studies	56% ± 15%	Explore
placental villous trophoblast	3 studies	84% ± 9%	Explore
lymphocyte	3 studies	44% ± 19%	Explore
neuroendocrine cell	3 studies	45% ± 18%	Explore
retina horizontal cell	3 studies	25% ± 11%	Explore
mucus secreting cell	3 studies	34% ± 12%	Explore
serous secreting cell	3 studies	42% ± 4%	Explore
tissue-resident macrophage	3 studies	28% ± 9%	Explore
Mueller cell	3 studies	25% ± 3%	Explore
germinal center B cell	3 studies	35% ± 10%	Explore
GABAergic neuron	3 studies	28% ± 8%	Explore
pancreatic ductal cell	3 studies	51% ± 10%	Explore
glial cell	3 studies	40% ± 20%	Explore
hepatocyte	3 studies	36% ± 23%	Explore
group 3 innate lymphoid cell	3 studies	37% ± 16%	Explore
melanocyte	3 studies	31% ± 5%	Explore
T-helper 17 cell	3 studies	42% ± 31%	Explore
interneuron	3 studies	25% ± 3%	Explore
T-helper 1 cell	3 studies	40% ± 21%	Explore
central memory CD8-positive, alpha-beta T cell	3 studies	30% ± 8%	Explore
double negative thymocyte	3 studies	42% ± 22%	Explore
CD4-positive, alpha-beta cytotoxic T cell	3 studies	41% ± 19%	Explore
progenitor cell of mammary luminal epithelium	3 studies	26% ± 5%	Explore

II. Expression across tissues

Name	Number of supported studies	Average coverage
peripheral blood	19 studies	42% ± 13%	Explore
lung	16 studies	40% ± 13%	Explore
brain	10 studies	28% ± 8%	Explore
intestine	9 studies	27% ± 11%	Explore
kidney	7 studies	32% ± 5%	Explore
placenta	5 studies	48% ± 23%	Explore
bone marrow	5 studies	38% ± 13%	Explore
eye	5 studies	25% ± 8%	Explore
liver	5 studies	37% ± 27%	Explore
lymph node	5 studies	33% ± 14%	Explore
pancreas	4 studies	42% ± 14%	Explore
uterus	4 studies	35% ± 21%	Explore
breast	4 studies	23% ± 4%	Explore
skin	3 studies	21% ± 4%	Explore

Tissue	GTEx Coverage	GTEx Average TPM	GTEx Number of samples	TCGA Coverage	TCGA Average TPM	TCGA Number of samples
ovary	100%	4590.60	180 / 180	100%	147.93	430 / 430
uterus	100%	4309.25	170 / 170	100%	266.91	459 / 459
esophagus	100%	10617.17	1443 / 1445	100%	251.71	183 / 183
thymus	100%	9660.34	653 / 653	100%	234.98	604 / 605
prostate	100%	5800.02	245 / 245	100%	252.91	501 / 502
intestine	100%	5103.72	966 / 966	100%	221.99	525 / 527
liver	100%	4417.62	225 / 226	100%	207.13	406 / 406
skin	100%	6933.58	1808 / 1809	100%	207.30	470 / 472
stomach	100%	6361.76	359 / 359	99%	206.83	284 / 286
lung	100%	7275.89	577 / 578	99%	305.56	1147 / 1155
breast	100%	7561.37	459 / 459	99%	210.83	1108 / 1118
brain	99%	4312.49	2616 / 2642	100%	157.45	705 / 705
bladder	100%	9869.62	21 / 21	99%	261.74	498 / 504
kidney	100%	6142.81	89 / 89	99%	157.22	890 / 901
pancreas	97%	3243.10	319 / 328	100%	189.78	178 / 178
adrenal gland	100%	4782.98	258 / 258	92%	85.70	211 / 230
adipose	100%	8418.56	1204 / 1204	0%	0	0 / 0
eye	0%	0	0 / 0	100%	218.24	80 / 80
lymph node	0%	0	0 / 0	100%	336.38	29 / 29
peripheral blood	100%	32468.02	929 / 929	0%	0	0 / 0
spleen	100%	9374.39	241 / 241	0%	0	0 / 0
tonsil	0%	0	0 / 0	100%	256.47	45 / 45
ureter	0%	0	0 / 0	100%	268.56	1 / 1
blood vessel	100%	5988.16	1329 / 1335	0%	0	0 / 0
muscle	99%	4289.04	791 / 803	0%	0	0 / 0
heart	93%	3373.79	804 / 861	0%	0	0 / 0
abdomen	0%	0	0 / 0	0%	0	0 / 0
bone marrow	0%	0	0 / 0	0%	0	0 / 0
diaphragm	0%	0	0 / 0	0%	0	0 / 0
gingiva	0%	0	0 / 0	0%	0	0 / 0
nasal cavity	0%	0	0 / 0	0%	0	0 / 0
nasopharynx	0%	0	0 / 0	0%	0	0 / 0
nose	0%	0	0 / 0	0%	0	0 / 0
placenta	0%	0	0 / 0	0%	0	0 / 0
spinal column	0%	0	0 / 0	0%	0	0 / 0

IV. Literature review

[source]

Gene name	TALDO1
Protein name	Transaldolase 1, isoform CRA_c (cDNA FLJ57988, highly similar to Transaldolase) Transaldolase (EC 2.2.1.2) Transaldolase 1
Synonyms	TALDO TAL hCG_18330 TALDOR
Description	FUNCTION: Catalyzes the rate-limiting step of the non-oxidative phase in the pentose phosphate pathway. Catalyzes the reversible conversion of sedheptulose-7-phosphate and D-glyceraldehyde 3-phosphate into erythrose-4-phosphate and beta-D-fructose 6-phosphate . Not only acts as a pentose phosphate pathway enzyme, but also affects other metabolite pathways by altering its subcellular localization between the nucleus and the cytoplasm (By similarity). . FUNCTION: Catalyzes the rate-limiting step of the non-oxidative phase in the pentose phosphate pathway. Catalyzes the reversible conversion of sedheptulose-7-phosphate and D-glyceraldehyde 3-phosphate into erythrose-4-phosphate and beta-D-fructose 6-phosphate. .
Accessions	B4DID5 ENST00000530440.1 ENST00000528097.5 P37837 E9PM01 ENST00000528070.5 F2Z393 ENST00000319006.8 [P37837-1] E9PKI8

GO_0005975	Biological process	carbohydrate metabolic process
GO_0006002	Biological process	fructose 6-phosphate metabolic process
GO_0009052	Biological process	pentose-phosphate shunt, non-oxidative branch
GO_0070062	Cellular component	extracellular exosome
GO_0005622	Cellular component	intracellular anatomical structure
GO_0005829	Cellular component	cytosol
GO_0005737	Cellular component	cytoplasm
GO_0005634	Cellular component	nucleus
GO_0048029	Molecular function	monosaccharide binding
GO_0004801	Molecular function	transaldolase activity
GO_0005515	Molecular function	protein binding

TALDO1 report

I. Expression across cell types

II. Expression across tissues

III. Associated gene sets

IV. Literature review